BigBear.ai (NYSE: BBAI), a frontrunner in artificial intelligence-driven solutions tailored for defense and national security, has recently announced an important development. The U.S. Department of…
March 10, 2025
March 10, 2025
Trevi Therapeutics Reports Positive Phase 2a RIVER Trial Results for Haduvio in Refractory Chronic Cough, Shares Surge ~35%
Trevi Therapeutics, Inc. (NASDAQ: TRVI) announced today that its investigational therapy Haduvio™ (oral nalbuphine ER) met the primary endpoint in the Phase 2a RIVER trial…
March 10, 2025
PRISM Mid-Day Market Moves: U.S. Stocks Sink as Growth Worries Mount; Tech, Bitcoin Lead Declines
U.S. equities traded sharply lower Monday midday, near session lows, following a higher Friday close. The S&P 500 is down over 8% from its February…
Biodexa Pharmaceuticals (NASDAQ: BDRX) has announced a successful Type C meeting with the FDA, clearing the path for its Phase 3 registrational trial of eRapa…
March 10, 2025
SciSparc and Clearmind Land South Korean Patent for Cocaine Addiction Therapy; Shares Surge 31%
SciSparc Ltd. (Nasdaq: SPRC) and Clearmind Medicine Inc. (Nasdaq: CMND) have announced the publication of a patent application by the South Korean Intellectual Property Office…
March 07, 2025
PRISM Mid-Day Moves: Markets Mixed as Payrolls Hold Steady, AI Stocks Struggle; Russia-Ukraine Ceasefire Talks in Focus
U.S. equities traded mixed this afternoon, as investors digested February’s largely in-line nonfarm payrolls report and ongoing geopolitical developments. While the labor market showed resilience,…
March 06, 2025
Scienture Holdings to Launch REZENOPY®: A High-Dose Naloxone Nasal Spray for Opioid Overdoses, Shares Up ~50%
Scienture Holdings, Inc. (NASDAQ: SCNX) is set to commercially launch REZENOPY®, a 10mg naloxone HCl nasal spray designed for emergency treatment of opioid overdoses. This…
The clinical-stage pharmaceutical company Plus Therapeutics, Inc. (Nasdaq: PSTV) has received Orphan Drug Designation (ODD) from the FDA for its targeted radiotherapeutic, Rhenium (186Re) Obisbemeda,…
March 06, 2025
NextNRG Reports Record-Breaking Revenue Growth, Expanding AI-Driven Energy and Fueling Solutions
NextNRG, Inc. (Nasdaq: NXXT), a leader in AI-powered energy solutions and mobile fuel delivery, has announced record year-over-year and sequential revenue growth for January 2025…
March 04, 2025
Quoin Pharmaceuticals Files Patent Applications for Innovative Topical Rapamycin Formulations to Treat Rare Diseases
The late clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, Quoin Pharmaceuticals (QNRX) has announced the filing of US and International patent…
March 04, 2025
Cyber Security Pioneer Cycurion Launches High Margin AI Platform to Be Implemented By Corporate Sector
The cyber security solutions emerger Cycurion (NASDAQ: CYCU) has launched its AI-powered ARx Platform into the corporate sector after successful implementation in the government and…
February 20, 2025
Soluna and Bit Digital Boost Their Bond and Expand Partnership to Exceed 12 MW in Hosting Capacity
The green data center developer Soluna Holdings (NASDAQ: SLNH) has signed a 12-month, 5.5 MW hosting contract with Bit Digital (NASDAQ: BTBT) at its Project…